Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Fibrinogen antagonists in Terumo's pipeline

June 28, 1996

Neutralase covered under Japanese patent

June 28, 1996

Texas Biotechnology and Synthelabo enter new argatroban collaboration

June 28, 1996

BCH-2763: BioChem Therapeutic's novel thrombin inhibitor

June 28, 1996

Nippon Mining reports on HV1C3

June 28, 1996

FDA approval of new indication for Genentech's Activase

June 21, 1996

LM-AS-013 development for peripheral vascular disorders terminated

June 21, 1996

E. Merck reports fibrinogen (gpIIb/IIIa) antagonists

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Modified factor VII described for coagulation-related disorders

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...